These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4261023

  • 1. A new broad spectrum inhibitor of esteroproteases, 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006).
    Maki M, Sasaki K.
    Tohoku J Exp Med; 1972 Mar; 106(3):233-48. PubMed ID: 4261023
    [No Abstract] [Full Text] [Related]

  • 2. Biological activities of leupeptins.
    Aoyagi T, Miyata S, Nanbo M, Kojima F, Matsuzaki M.
    J Antibiot (Tokyo); 1969 Nov; 22(11):558-68. PubMed ID: 4243683
    [No Abstract] [Full Text] [Related]

  • 3. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM, Ambrus JL, Lassman HB, Mink IB.
    Ann N Y Acad Sci; 1968 Jun 28; 146(2):430-47. PubMed ID: 4239437
    [No Abstract] [Full Text] [Related]

  • 4. [Inhibition of plasmin system by 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006) (AUTHOR'S TRANSL)].
    Maki M.
    Rinsho Ketsueki; 1972 Feb 28; 13(1):30-7. PubMed ID: 4281839
    [No Abstract] [Full Text] [Related]

  • 5. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H.
    Thromb Diath Haemorrh; 1973 May 10; 29(2):253-75. PubMed ID: 4271586
    [No Abstract] [Full Text] [Related]

  • 6. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L, Tse AO, Semar M, Johnson AJ.
    Ann N Y Acad Sci; 1968 Jun 28; 146(2):659-72. PubMed ID: 4239440
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of trypsin, plasmin, thrombin and kallikrein by various esters of guanidino- and amidino-acids.
    Akashi H, Ariki T, Kato M, Kozaki Y, Irisawa T, Muramatu M.
    Biol Pharm Bull; 1994 Mar 28; 17(3):446-8. PubMed ID: 8019515
    [Abstract] [Full Text] [Related]

  • 8. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK, Mitchell PS, Gorstein F.
    Thromb Diath Haemorrh; 1967 May 31; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract] [Full Text] [Related]

  • 9. Plasminogen-plasmin system. 3. Kinetics of plasminogen activation and inhibition of plasminogen-plasmin system by some synthetic inhibitors.
    Iwamoto M, Abiko Y, Shimizu M.
    J Biochem; 1968 Dec 31; 64(6):759-67. PubMed ID: 4238017
    [No Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of -amino acid esters on trypsin, plasmin, plasma kallikrein and thrombin.
    Muramatu M, Fujii S.
    Biochim Biophys Acta; 1971 Jul 21; 242(1):203-8. PubMed ID: 4256355
    [No Abstract] [Full Text] [Related]

  • 11. Studies of kallikrein inhibitors in potatoes. II. Effect of potato kallikrein inhibitors on various kallikreins and other proteases.
    Hojima Y, Moriya H, Moriwaki C.
    J Biochem; 1971 Jun 21; 69(6):1027-32. PubMed ID: 4253726
    [No Abstract] [Full Text] [Related]

  • 12. [New polyvalent protease inhibitors for trypsin, chymotrypsin, plasmin and kallikreins from snails (Helix pomatia)].
    Tschesche H, Dietl T, Marx R, Fritz H.
    Hoppe Seylers Z Physiol Chem; 1972 Mar 21; 353(3):483-6. PubMed ID: 4260409
    [No Abstract] [Full Text] [Related]

  • 13. Inhibitors of the acrosomal proteinase acrosin: human urinary trypsin inhibitor (UTI) and 4-(2-carboxyethyl) phenyl trans 4-aminomethylcyclohexanecarboxylate hydrochloride (DV-1006).
    Sumi H, Toki N.
    Experientia; 1980 Sep 15; 36(9):1103-4. PubMed ID: 6998719
    [Abstract] [Full Text] [Related]

  • 14. [Behavior of the kallikrein inhibitor against enzymes, 3. Behavior of the kallikrein inhibitor from bovine lung against proteases].
    Kraut H, Bhargava N.
    Hoppe Seylers Z Physiol Chem; 1967 Nov 15; 348(11):1498-9. PubMed ID: 4231141
    [No Abstract] [Full Text] [Related]

  • 15. Reaction of a tumour-associated trypsin inhibitor with serine proteinases associated with coagulation and tumour invasion.
    Turpeinen U, Koivunen E, Stenman UH.
    Biochem J; 1988 Sep 15; 254(3):911-4. PubMed ID: 2461702
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor.
    Dubber AH, McNicol GP, Uttley D, Douglas AS.
    Br J Haematol; 1968 Jan 15; 14(1):31-49. PubMed ID: 4229180
    [No Abstract] [Full Text] [Related]

  • 17. Differences in active center reactivity of trypsin homologs. Specific inactivation of thrombin by nitrophenyl p-amidinophenylmethanesulfonate.
    Wong SC, Shaw E.
    Arch Biochem Biophys; 1974 Apr 02; 161(2):536-43. PubMed ID: 4365206
    [No Abstract] [Full Text] [Related]

  • 18. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
    Landman H, Markwardt F, Perlewitz J.
    Thromb Diath Haemorrh; 1969 Dec 31; 22(3):552-68. PubMed ID: 5382290
    [No Abstract] [Full Text] [Related]

  • 19. [Inhibitory effect of 4-(2-carboxyethyl) phenyl trans-4-aminomethyl cyclohexane carboxylate hydrochloride on fibrinolysis, esterolysis and proteolysis and its degradation by serum esterases: in vitro study].
    Nagamatsu Y, Matsumoto M, Yamamoto J, Okamoto U.
    Nihon Ketsueki Gakkai Zasshi; 1973 Apr 31; 36(2):150-8. PubMed ID: 4738466
    [No Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of -guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombin.
    Muramatu M, Fujii S.
    Biochim Biophys Acta; 1972 Apr 07; 268(1):221-4. PubMed ID: 4259678
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.